163 related articles for article (PubMed ID: 16118215)
1. Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences.
Singh M; Krajewski M; Mikolajka A; Holak TA
J Biol Chem; 2005 Nov; 280(45):37868-76. PubMed ID: 16118215
[TBL] [Abstract][Full Text] [Related]
2. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
Dick FA; Sailhamer E; Dyson NJ
Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361
[TBL] [Abstract][Full Text] [Related]
3. The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.
Wang J; Zhou D; Prabhu A; Schlegel R; Yuan H
PLoS Pathog; 2010 Sep; 6(9):e1001089. PubMed ID: 20824099
[TBL] [Abstract][Full Text] [Related]
4. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
Ledl A; Schmidt D; Müller S
Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
[TBL] [Abstract][Full Text] [Related]
5. Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins.
Dick FA; Dyson NJ
J Virol; 2002 Jun; 76(12):6224-34. PubMed ID: 12021356
[TBL] [Abstract][Full Text] [Related]
6. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
7. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.
Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696
[TBL] [Abstract][Full Text] [Related]
8. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7.
Lee JO; Russo AA; Pavletich NP
Nature; 1998 Feb; 391(6670):859-65. PubMed ID: 9495340
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein.
Patrick DR; Oliff A; Heimbrook DC
J Biol Chem; 1994 Mar; 269(9):6842-50. PubMed ID: 8120046
[TBL] [Abstract][Full Text] [Related]
10. Interactions of SV40 large T antigen and other viral proteins with retinoblastoma tumour suppressor.
Lee C; Cho Y
Rev Med Virol; 2002; 12(2):81-92. PubMed ID: 11921304
[TBL] [Abstract][Full Text] [Related]
11. Binding to retinoblastoma pocket domain does not alter the inter-domain flexibility of the J domain of SV40 large T antigen.
Williams CK; Vaithiyalingam S; Hammel M; Pipas J; Chazin WJ
Arch Biochem Biophys; 2012 Feb; 518(2):111-8. PubMed ID: 22227098
[TBL] [Abstract][Full Text] [Related]
12. Binding of the LXCXE insulin motif to a hexapeptide derived from retinoblastoma protein.
Radulescu RT; Bellitti MR; Ruvo M; Cassani G; Fassina G
Biochem Biophys Res Commun; 1995 Jan; 206(1):97-102. PubMed ID: 7818556
[TBL] [Abstract][Full Text] [Related]
13. Determination of the binding affinity of different human papillomavirus E7 proteins for the tumour suppressor pRb by a plate-binding assay.
Dong WL; Caldeira S; Sehr P; Pawlita M; Tommasino M
J Virol Methods; 2001 Oct; 98(1):91-8. PubMed ID: 11543887
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR
Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611
[TBL] [Abstract][Full Text] [Related]
15. Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein.
Chan HM; Smith L; La Thangue NB
Oncogene; 2001 Sep; 20(43):6152-63. PubMed ID: 11593423
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
17. Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein.
Clements A; Johnston K; Mazzarelli JM; Ricciardi RP; Marmorstein R
Biochemistry; 2000 Dec; 39(51):16033-45. PubMed ID: 11123931
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for recognition of the tumor suppressor protein PTPN14 by the oncoprotein E7 of human papillomavirus.
Yun HY; Kim MW; Lee HS; Kim W; Shin JH; Kim H; Shin HC; Park H; Oh BH; Kim WK; Bae KH; Lee SC; Lee EW; Ku B; Kim SJ
PLoS Biol; 2019 Jul; 17(7):e3000367. PubMed ID: 31323018
[TBL] [Abstract][Full Text] [Related]
19. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein.
Wu EW; Clemens KE; Heck DV; Münger K
J Virol; 1993 Apr; 67(4):2402-7. PubMed ID: 8445736
[TBL] [Abstract][Full Text] [Related]
20. Short linear motif core and flanking regions modulate retinoblastoma protein binding affinity and specificity.
Palopoli N; González Foutel NS; Gibson TJ; Chemes LB
Protein Eng Des Sel; 2018 Mar; 31(3):69-77. PubMed ID: 29370437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]